Biblio

Found 2 results

Filters: Author is Bloechl-Daum, B [Clear All Filters]

2016

H. - G. Eichler, Bloechl-Daum, B., Bauer, P., Bretz, F., Brown, J., Hampson, L. V., Honig, P., Krams, M., Leufkens, H., Lim, R., Lumpkin, M. M., Murphy, M. J., Pignatti, F., Posch, M., Schneeweiss, S., Trusheim, M., and Koenig, F., ““Threshold-crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?”, Clinical Pharmacology & Therapeutics, vol. 100, pp. 699–712, 2016.

2015

H. - G. Eichler, Baird, L. G., Barker, R., Bloechl-Daum, B., Børlum-Kristensen, F., Brown, J., Chua, R., Del Signore, S., Dugan, U., Ferguson, J., Garner, S., Goettsch, W., Haigh, J., Honig, P., Hoos, A., Huckle, P., Kondo, T., Le Cam, Y., Leufkens, H., Lim, R., Longson, C., Lumpkin, M., Maraganore, J., O'Rourke, B., Oye, K., Pezalla, E., Pignatti, F., Raine, J., Rasi, G., Salmonson, T., Samaha, D., Schneeweiss, S., Siviero, P. D., Skinner, M., ,, Tominaga, T., Trusheim, M. R., Tunis, S., Unger, T. F., Vamvakas, S., and Hirsch, G., “From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients”, Clinical Pharmacology & Therapeutics, vol. 97, pp. 234–246, 2015.